Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 5 (2008), Issue 1 (January)

1. Psychotropic medication patterns among youth in foster care.
   Pediatrics, 121(1): e157-63. [Abstract] [Full-text]
2. The prevalence of metabolic syndrome in patients with bipolar disorder.
   J Affect Disord, 106(1): 197-201. [Abstract] [Full-text]
3. Modal subcomponents of metabolic syndrome in patients with bipolar disorder.
   J Affect Disord, 106(1): 91-7. [Abstract] [Full-text]
4. Suicidal events and accidents in 216 first-episode bipolar I disorder patients: Predictive factors.
   J Affect Disord, 106(1): 179-84. [Abstract] [Full-text]
5. No association between a TPH2 promoter polymorphism and mood disorders or monoamine turnover.
   J Affect Disord, 106(1): 117-21. [Abstract] [Full-text]
6. Assessment of depressive symptom severity among patients with co-occurring bipolar disorder and substance dependence.
   J Affect Disord, 106(1): 83-89. [Abstract] [Full-text]
7. Cocaine abuse and the bipolar spectrum in 1090 heroin addicts: Clinical observations and a proposed pathophysiologic model.
   J Affect Disord, 106(1): 55-61. [Abstract] [Full-text]
8. The empirical redefinition of the psychometric criteria for remission in bipolar disorder.
   J Affect Disord, 106(1): 153-8. [Abstract] [Full-text]
9. Validation of the Chinese version of the Hypomania Checklist (HCL-32) as an instrument for detecting hypo(mania) in patients with mood disorders.
   J Affect Disord, 106(1): 133-43. [Abstract] [Full-text]
10. Changes in allergy symptoms and depression scores are positively correlated in patients with recurrent mood disorders exposed to seasonal peaks in aeroallergens.
    ScientificWorldJournal, 7: 1968-77. [Abstract] [Full-text]
11. Novel Drugs and Therapeutic Targets for Severe Mood Disorders.
    Neuropsychopharmacology. [Abstract] [Full-text]
12. The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior.
    J Neurosci, 28(1): 68-79. [Abstract] [Full-text]
13. Clinical and neurocognitive correlates of insight in patients with bipolar I disorder in remission.
    Acta Psychiatr Scand, 117(1): 28-34. [Abstract] [Full-text]
14. Psychosocial interventions for the prevention of relapse in bipolar disorder: systematic review of controlled trials.
    Br J Psychiatry, 192: 5-11. [Abstract] [Full-text]
15. Characteristics of children with autism spectrum disorders who received services through community mental health centers.
    Autism, 12(1): 65-82. [Abstract] [Full-text]
16. The phenomenology and diagnosis of psychiatric illness in people with Prader-Willi syndrome.
    Psychol Med. [Abstract] [Full-text]
17. Family-based association of FKBP5 in bipolar disorder.
    Mol Psychiatry. [Abstract] [Full-text]
18. Family-based association study of lithium-related and other candidate genes in bipolar disorder.
    Arch Gen Psychiatry, 65(1): 53-61. [Abstract] [Full-text]
19. Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich cohort study.
    Arch Gen Psychiatry, 65(1): 47-52. [Abstract] [Full-text]
20. Neural connectivity in children with bipolar disorder: impairment in the face emotion processing circuit.
    J Child Psychol Psychiatry, 49(1): 88-96. [Abstract] [Full-text]
21. Increased volume of the amygdala and hippocampus in bipolar patients treated with lithium.
    Neuroreport, 19(2): 221-4. [Abstract] [Full-text]
22. Mitochondrial DNA-dependent effects of valproate on mitochondrial calcium levels in transmitochondrial cybrids.
    Int J Neuropsychopharmacol, 11(1): 71-8. [Abstract] [Full-text]
23. Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation.
    Int J Neuropsychopharmacol, 11(1): 119-30. [Abstract] [Full-text]
24. Differences in the ICD-10 Diagnostic Subtype of Depression in Bipolar Disorder Compared to Recurrent Depressive Disorder.
    Psychopathology, 41(3): 141-146. [Abstract] [Full-text]
25. IMPA1 is Essential for Embryonic Development and Lithium-Like Pilocarpine Sensitivity.
    Neuropsychopharmacology, 33(3): 674-84. [Abstract] [Full-text]
26. The effect of mood stabilizer lithium on expression and activity of glutathione s-transferase isoenzymes.
    Neuroscience, 151(2): 518-24. [Abstract] [Full-text]
27. Dysthymic and anxiety-related personality traits in bipolar spectrum illness.
    J Affect Disord. [Abstract] [Full-text]
28. Electroconvulsive therapy in the treatment of mixed states in bipolar disorder.
    Eur Psychiatry. [Abstract] [Full-text]
29. A beta-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior.
    Cell, 132(1): 125-36. [Abstract] [Full-text]
30. Delirious mania: Clinical features and treatment response.
    J Affect Disord. [Abstract] [Full-text]
31. Temperament and character dimensions in bipolar I disorder: A comparison to healthy controls.
    J Psychiatr Res. [Abstract] [Full-text]
32. Shared Gene Expression Alterations in Schizophrenia and Bipolar Disorder.
    Biol Psychiatry. [Abstract] [Full-text]
33. Early postpartum symptoms in puerperal psychosis.
    BJOG, 115(3): 348-53. [Abstract] [Full-text]
34. No higher risk of myocardial infarction among bipolar patients in a 6-year follow-up of acute mood episodes.
    Psychosom Med, 70(1): 73-6. [Abstract] [Full-text]
35. Treatment adherence and illness insight in veterans with bipolar disorder.
    J Nerv Ment Dis, 196(1): 16-21. [Abstract] [Full-text]
36. Are anomalous perceptual experiences necessary for delusions?
    J Nerv Ment Dis, 196(1): 3-8. [Abstract] [Full-text]
37. Association study between the Down syndrome cell adhesion molecule (DSCAM) gene and bipolar disorder.
    Psychiatr Genet, 18(1): 1-10. [Abstract] [Full-text]
38. Clinical diagnoses in young offspring from eastern Québec multigenerational families densely affected by schizophrenia or bipolar disorder.
    Acta Psychiatr Scand, 117(2): 118-26. [Abstract] [Full-text]
39. Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional study.
    Acta Psychiatr Scand, 117(2): 133-8. [Abstract] [Full-text]
40. Further support for association of the mitochondrial complex I subunit gene NDUFV2 with bipolar disorder.
    Bipolar Disord, 10(1): 105-10. [Abstract] [Full-text]
41. Pituitary gland volume in adolescent and young adult bipolar and unipolar depression.
    Bipolar Disord, 10(1): 101-4. [Abstract] [Full-text]
42. Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide.
    Bipolar Disord, 10(1): 87-94. [Abstract] [Full-text]
43. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up.
    Bipolar Disord, 10(1): 79-86. [Abstract] [Full-text]
44. The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder.
    Bipolar Disord, 10(1): 67-78. [Abstract] [Full-text]
45. Retrospective parent report of psychiatric histories: do checklists reveal specific prodromal indicators for postpubertal-onset pediatric bipolar disorder?
    Bipolar Disord, 10(1): 56-66. [Abstract] [Full-text]
46. Familial aggregation of postpartum mood symptoms in bipolar disorder pedigrees.
    Bipolar Disord, 10(1): 38-44. [Abstract] [Full-text]
47. Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder.
    Bipolar Disord, 10(1): 1-37. [Abstract] [Full-text]
48. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder.
    Mol Psychiatry, 13(2): 197-207. [Abstract] [Full-text]
49. Determinants of Voluntary vs. Involuntary Admission in Bipolar Disorder and the Impact of Adherence.
    Pharmacopsychiatry, 41(1): 29-36. [Abstract] [Full-text]
50. Association between the PPP3CC gene, coding for the calcineurin gamma catalytic subunit, and bipolar disorder.
    Behav Brain Funct, 4(1): 2. [Abstract] [Full-text]
51. Behavioural sensitization to repeated sleep deprivation in a mice model of mania.
    Behav Brain Res, 187(2): 221-7. [Abstract] [Full-text]
52. Clock genes beyond the clock: CLOCK genotype biases neural correlates of moral valence decision in depressed patients.
    Genes Brain Behav, 7(1): 20-5. [Abstract] [Full-text]
53. Impulsivity: differential relationship to depression and mania in bipolar disorder.
    J Affect Disord, 106(3): 241-8. [Abstract] [Full-text]
54. Risk of psychosis exacerbation by tricyclic antidepressants in unipolar Major Depressive Disorder with psychotic features.
    J Affect Disord, 106(3): 279-84. [Abstract] [Full-text]
55. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications.
    Int J Neuropsychopharmacol. [Abstract] [Full-text]
56. Genetic association study of BDNF in depression: Finding from two cohort studies and a meta-analysis.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
57. Initial association of NR2E1 with bipolar disorder and identification of candidate mutations in bipolar disorder, schizophrenia, and aggression through resequencing.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
58. The nursing of outpatients with a bipolar disorder: what nurses actually do.
    Arch Psychiatr Nurs, 22(1): 3-11. [Abstract] [Full-text]
59. Low prevalence of neurologic and psychiatric manifestations in children with gluten sensitivity.
    J Pediatr, 152(2): 244-9. [Abstract] [Full-text]
60. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
    J Clin Psychopharmacol, 28(1): 13-20. [Abstract] [Full-text]
61. Family study of subthreshold psychopathology in a community sample.
    Psychol Med, 38(2): 187-98. [Abstract] [Full-text]
62. Diagnostic co-morbidity in 2300 psychiatric out-patients presenting for treatment evaluated with a semi-structured diagnostic interview.
    Psychol Med, 38(2): 199-210. [Abstract] [Full-text]
63. Augmentation of antidepressants with atypical antipsychotics: a review of the current literature.
    J Psychiatr Pract, 14(1): 34-44. [Abstract] [Full-text]
64. Promotion of choice in the care of people with bipolar disorder: a mental health nursing perspective.
    J Psychiatr Ment Health Nurs, 15(2): 87-92. [Abstract] [Full-text]
65. Implementing clinical guidelines for bipolar disorder.
    Psychol Psychother. [Abstract] [Full-text]
66. A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(1): 204-8. [Abstract] [Full-text]
67. Retinal dysfunctions in schizophrenia.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(1): 297-300. [Abstract] [Full-text]
68. Power based association analysis (PBAT) of serotonergic and noradrenergic polymorphisms in bipolar patients with suicidal behaviour.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(1): 197-203. [Abstract] [Full-text]
69. Lithium effects on brain glutamatergic and GABAergic systems of healthy volunteers as measured by proton magnetic resonance spectroscopy.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(1): 249-56. [Abstract] [Full-text]
70. Olanzapine for the treatment of bipolar disorder in children and adolescents.
    Expert Opin Pharmacother, 9(3): 467-74. [Abstract] [Full-text]
71. Advance directives in bipolar disorder, a cognitive behavioural conceptualization.
    Int J Law Psychiatry, 31(1): 1-8. [Abstract] [Full-text]
72. Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
73. The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement.
    Mol Psychiatry. [Abstract] [Full-text]
74. A genome screen of 35 bipolar affective disorder pedigrees provides significant evidence for a susceptibility locus on chromosome 15q25-26.
    Mol Psychiatry. [Abstract] [Full-text]
75. Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency.
    Proc Natl Acad Sci U S A, 105(4): 1333-8. [Abstract] [Full-text]
76. Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia.
    Psychopharmacology (Berl), 196(3): 417-29. [Abstract] [Full-text]
77. Design of electrochemical biosensor systems for the detection of specific DNA sequences in PCR-amplified nucleic acids related to the catechol-O-methyltransferase Val108/158Met polymorphism based on intrinsic guanine signal.
    Anal Chem, 80(3): 588-96. [Abstract] [Full-text]
78. Mitochondrially Mediated Plasticity in the Pathophysiology and Treatment of Bipolar Disorder.
    Neuropsychopharmacology. [Abstract] [Full-text]
79. Prevalence and correlates of overweight in drug-naïve patients with bipolar disorder.
    J Affect Disord. [Abstract] [Full-text]
80. Differential interactions between comorbid anxiety disorders and substance use disorder in rapid cycling bipolar I or II disorder.
    J Affect Disord. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.